Last reviewed · How we verify

NCT06043180: PREDICT-TAVI

Outcome Prediction in Patients With Aortic Stenosis After TAVI

Not yet recruiting Last updated 21 September 2023
What this trial tests

trial testing Transcatheter aortic valve implantation in Aortic Stenosis, Severe in 69 participants. Not yet recruiting.

Timeline
1 October 2023
Primary endpoint
1 February 2026
1 February 2027

Quick facts

Lead sponsorGuy's and St Thomas' NHS Foundation Trust
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment69
Start date1 October 2023
Primary completion1 February 2026
Estimated completion1 February 2027
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Guy's and St Thomas' NHS Foundation Trust

Who can join

18 and older, any sex, with Aortic Stenosis, Severe. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will investigate changes right ventricular function and functional recovery metrics after transcatheter aortic valve implantation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Transcatheter aortic valve implantation

Trials testing the same drug.

Other recruiting trials for Aortic Stenosis, Severe

Currently open trials in the same condition.

Other Guy's and St Thomas' NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06043180.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing